Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy
Bone Marrow Transplantation2011Vol. 47(9), pp. 1217–1221
Citations Over TimeTop 21% of 2011 papers
Per Ljungman, Anna Locasciulli, Valle Gómez-Garcı́a de Soria, A N Békássy, Lorentz Brinch, Ildefonso Espigado, A Ferrant, Ian M. Franklin, James M. O’Riordan, Montserrat Rovira, Peter J. Shaw, Hermann Einsele, for the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation
Related Papers
- → Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era(2018)35 cited
- → Treatment of hepatitis C with interferon and ribavirin(2000)46 cited
- → Ribavirin Enhances the Action of Interferon-α against Hepatitis C Virus by Promoting the p53 Activity through the ERK1/2 Pathway(2012)14 cited
- → Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production(2015)8 cited
- → Small Steps Toward a Better Treatment for Chronic Hepatitis C Infection: Mericitabine, Pegylated Interferon, and Ribavirin in the PROPEL and JUMP-C Trials(2013)2 cited